GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Short-Term Debt

LTR Pharma (ASX:LTP) Short-Term Debt : A$0.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Short-Term Debt?

LTR Pharma's Short-Term Debt for the quarter that ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma's quarterly Short-Term Debt declined from Jun. 2021 (A$0.36 Mil) to Jun. 2022 (A$0.00 Mil) but then stayed the same from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil).

LTR Pharma's annual Short-Term Debt declined from Jun. 2021 (A$0.36 Mil) to Jun. 2022 (A$0.00 Mil) but then stayed the same from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil).

LTR Pharma Short-Term Debt Historical Data

The historical data trend for LTR Pharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Short-Term Debt Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Short-Term Debt
0.36 - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Short-Term Debt 0.36 - -

LTR Pharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

LTR Pharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Short-Term Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines